These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2498278)

  • 21. In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.
    Kresken M; Körber-Irrgang B; Läuffer J; Decker-Burgard S; Davies T
    Int J Antimicrob Agents; 2011 Jul; 38(1):70-5. PubMed ID: 21514795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
    Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
    Chandrasekar PH; Crane LR; Bailey EJ
    J Antimicrob Chemother; 1987 Mar; 19(3):321-9. PubMed ID: 3106305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
    Majtán V; Hostacká A
    Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
    Pankey GA; Ashcraft DS
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.
    Bustamante CI; Drusano GL; Wharton RC; Wade JC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):632-4. PubMed ID: 3111357
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of synergy between ofloxacin, ceftazidime, and tobramycin against Pseudomonas aeruginosa.
    Madaras-Kelly KJ; Moody J; Larsson A; Baeker Hovde L; Rotschafer JC
    Chemotherapy; 1997; 43(2):108-17. PubMed ID: 9084919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
    Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
    Canis F; Cavallo JD; Husson MO
    Pathol Biol (Paris); 1997 May; 45(5):420-3. PubMed ID: 9296096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 33. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J; Hirai CK; Takenaka IM
    J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.
    Comber KR; Basker MJ; Osborne CD; Sutherland R
    Antimicrob Agents Chemother; 1977 Jun; 11(6):956-64. PubMed ID: 406837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.
    Reyes MP; El-Khatib MR; Brown WJ; Smith F; Lerner AM
    J Infect Dis; 1979 Aug; 140(2):192-202. PubMed ID: 113468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
    Pavillard ER; Miles H
    Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.